ClinicalTrials.gg
Enrolling by invitationNCT06512961Updated Sep 18, 2026

Applicability of Tissue Flossing for Blood Flow Restriction in the Upper Limb: Reliability and Performance Analysis

An interventional study of Tissue Flossing and Blood Flow Restriction Cuff in Hypertrophy and Muscle Strength, sponsored by Paulista University. Enrolling by invitation at 1 site in Brazil. Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by Paulista University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

Blood flow restriction (BFR) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

Read the detailed description

Objectives: to evaluate the intra- and inter-rater reliability of the occlusion pressure generated by TF, investigate the reproducibility of TF application on different days and compare TF with traditional RFS in terms of muscle gains.

Methods: the study is divided into two stages: First stage, randomized controlled crossover clinical trial, 80 healthy individuals aged 18 to 30 years old evaluated to determine the reliability of the TF. Participants will follow one of two types of randomization, with exclusions based on health criteria. Assessments include anthropometric characteristics, determination of occlusion pressure (POT), identification of 40% and 80% of POT, flow data and arterial diameter after TF application. Statistical analysis will use the intraclass correlation index (ICC) and specific models for intra- and inter-rater analyses. Second stage, randomized controlled clinical trial with parallel groups, 34 participants will be evaluated over fifteen weeks. The initial procedures involve anthropometric assessments, POT determination, myotonometry, ultrasound, perceptual scale and 1RM test, applied to both upper limbs. Participants will perform a upper limb training protocol using RFS or TF, following myotonometric and perceptual assessments. After training, final assessments will measure the same parameters initially assessed. Statistical analysis will use normality tests, Generalized Mixed Models and effect size analysis in SPSS software, with a significance level of p\<0.05. Expected results: This study is expected to provide information on the reliability and reproducibility of TF in generating occlusion pressure. Furthermore, the investigatorsF seek to validate TF by comparing it with traditional RFS in terms of muscle gains. If effective, TF could become an affordable option to promote muscle gains, in different application scenarios.

Participants will be duly informed about the procedures and objectives of this study, and after agreeing, they will sign an informed consent form, effectively becoming part of it. In the consent form, participants will be asked if they agree to the use of their data if they choose to withdraw from the study. Participants will also be asked for permission for the research team to share relevant data with people at universities participating in the research or regulatory authorities, where relevant. The study were approved to the Research Ethics Committee of FCT/UNESP, Presidente Prudente, SP, Brazil.

02

Conditions studied

  • Hypertrophy
  • Muscle Strength

Browse trials for

Keywords

  • Tissue flossing
  • Blood flow restriction
03

In context

Hypertrophy

139 studies on the registry are indexed under Hypertrophy; 22 are open to participants now.

This study's planned enrollment of 34 is close to the median of 34 across 112 interventional studies indexed under Hypertrophy.

Browse Hypertrophy studies →

Lead sponsor

Paulista University is the lead sponsor of 23 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals who present one or more of the following characteristics will not be included:
  • 1 presence of any health condition that contraindicates or prevents exercise;
  • 2 diabetes and diagnosed high blood pressure;
  • 3 inflammatory, psychiatric, cardiovascular and/or respiratory rheumatological disease; - -4 being dependent on alcohol, consuming drugs and/or being a smoker;
  • 5 history of knee surgery (e.g., meniscal repair and ligament reconstruction) or recent upper limb musculoskeletal injury that may impair performance during tests or interventions (e.g., muscle injury, tendinopathy, patellofemoral pain and/or back pain column in the last six months);
  • 6 use of ergogenic supplements to improve physical performance and/or muscle mass and/or vasoactive medications;
  • 7 having one or more risk factors predisposing to thromboembolism

Exclusion criteria

Exclusion Criteria:

  • Participants will be excluded from the study if they:
  • 1 have a health problem that does not allow them to continue;
  • 2 wish to leave the study;
  • 3 not sign the consent form
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
34 participants (estimated)

Study arms

  • Active comparator
    Group Traditional BFR

    This group will perform the training protocol with traditional BFR, using a pressure cuff as an occluder on both arms.

    Device: Blood Flow Restriction Cuff · Other: Training Protocol

  • Experimental
    Group BFR TF

    This group will perform the training protocol with BFR using TF on both arms.

    Device: Tissue Flossing · Other: Training Protocol

Interventions

  • DeviceTissue Flossing

    Tissue Flossing ia a elastic band that when applied exerts an external pressure above or below a muscle or joint of the extremities.

  • DeviceBlood Flow Restriction Cuff

    Inflatable device that exerts an external pressure above a muscle or joint of the extremities.

  • OtherTraining Protocol

    The upper limb resistance training protocol will follow that recommended in the study by Patterson et al. for resistance training, and will last 15weeks, with 3 training sessions per week, with a day break between sessions.

06

What researchers measure

Primary outcomes

  1. Occlusion pressures (AOP, 80% and 40% of AOP)

    To determine the AOP, the Doppler equipment transducer will be used, which will be positioned over the brachii artery to capture the auscultatory pulse. A blood pressure cuff will be fixed to the participant's thigh close to the region of the inguinal fold of the dominant limb, and then with the inflatable region of the cuff on the medial portion of the thigh covering the femoral artery, it will be progressively inflated, waiting 15 seconds every 30 mmHg until the point at which the auscultatory pulse of the brachii artery is interrupted.

    Time frame: 3 days

  2. Assessment of arterial flow and diameter

    A Sonoline Sienna® vascular ultrasound will be used combined with a 40mm B-mode ultrasonic transducer with a 7.5 MHz linear beam, which will be coated with gel for acoustic contact and positioned longitudinally to the posterior brachii artery, enabling variables to be assessed. Doppler flow measurements of upper limb (peak systolic velocity \[cm/s\], end-diastolic velocity \[cm/s\] and arterial diameter).

    Time frame: 3 days

  3. Perceptual parameter

    The perceptual parameter will be evaluated using a Borg CR10+ scale, representing the perception of discomfort, 0 represents no discomfort and 10 extremely uncomfortable.

    Time frame: 3 days

  4. Tissue Flossing Assessment

    The application of tissue flossing on the leg will be carried out by always passing the elastic tape with 50% of the tape over the next strip, until the end of the elastic tape.

    Time frame: 3 days

  5. Weight

    It will be collected with a weight balance

    Time frame: 3 days

  6. Height

    It will be collected with a stadiometer

    Time frame: 1 day

  7. Body Fat

    It will be collected with a adipometer

    Time frame: 1 day

  8. Arterial pressure

    It will be collected with a sphygmomanometer

    Time frame: 1 day

  9. Perimetry of the dominant upper limb

    It will be defined by the Waterloo Footedness

    Time frame: 1 day

  10. Limb length

    Identified with a measuring tape

    Time frame: 1 day

  11. Perceived exertion scale

    Adapted BORG scale, with 0 being "no effort" and 10 "maximum effort".

    Time frame: up to 15 weeks

  12. Method preference

    Participants must answer a brief questionnaire about their preference for one of the BFR methods carried out, and justify why they chose it.

    Time frame: up to 15 weeks

  13. 1 Maximum Repetition Test

    The warm-up will include a series of 6 to 10 repetitions, using approximately 50% of the estimated load for the first attempt of the test (44). This warm-up will not only prepare participants but also familiarize them with the movement. The determination of the initial warm-up load will be made subjectively by the researcher responsible for the study, considering the participant's height, body mass and training experience as reference points (45). After the warm-up phase, up to five attempts will be given to find the 1RM, with intervals of 3 to 5 minutes between them (46). The load adjustment for subsequent attempts will be determined by the subjective perception of effort, according to the BORG scale, where the greater the perception of effort, the lower the percentage of load added for the next attempt. The 1RM will be established as the maximum load at which the participant can perform one repetition without compensation.

    Time frame: up to 15 weeks

  14. Myotonometry

    Myotonometry will be assessed using the MyotonPRO® tool, which consists of a portable, wireless and non-invasive device. The measurement will be carried out once, and in each shot, the following myotonometry parameters will be calculated: the state of tension (tone) and biomechanical properties (rigidity and elasticity).

    Time frame: up to 15 weeks

  15. Ultrasound

    The assessment of the muscular structure will be carried out using ultrasound images of the participant's upper limbs, which will be captured using BodyMetrix BX-2000. Participants will be assessed in the supine position with arms fully extended and muscles relaxed. The ultrasound transducer will be covered with water-soluble transmission gel and positioned perpendicular to the skin over the muscle.

    Time frame: up to 15 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Jun 2026, 10 months.

Of 65 non-industry interventional studies with no phase under Hypertrophy, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 22. This study's 10 months is below that.

Counting every sponsor, half of 78 studies reached it within 13 months; a quarter within 6 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 25, 2024
First posted
Jul 22, 2024
StartActual
Aug 1, 2025
Primary completionActual
Jun 15, 2026
CompletionEst.
Jul 15, 2027
Last update
Sep 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06512961
Lead sponsor
Paulista University
Collaborators
Coordination for the Improvement of Higher Education Personnel
Responsible party
Franciele Marques Vanderle (Professor, Paulista University) — Principal investigator
First posted
Jul 22, 2024
Start date
Aug 1, 2025
Primary completion
Jun 15, 2026
Completion
Jul 15, 2027 (estimated)
Last update
Sep 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion